Form 4/AAMENDMENTCTMXCIK 0001501989

CytomX Therapeutics, Inc.

Name: SEC EDGAR filing 0001610717-25-000020
Creator: CytomX Therapeutics, Inc.
License: https://www.usa.gov/government-works

Insider transaction (Form 4/A) filed February 10, 2025.

Statement of changes in beneficial ownership filed by company officers, directors, and 10%+ owners.

Read the filing on SEC.gov All documents in this filing

New to the Form 4/A? What it is and how to read one

Filing facts

Accession number: 0001610717-25-000020
Filer: CytomX Therapeutics, Inc.
Ticker: CTMX
CIK: 0001501989
Form type: Form 4/A
Form description: Insider transaction
Filed at: February 10, 2025
Period of report: February 4, 2025
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 12.2 KB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from CytomX Therapeutics, Inc.

See all 43 filings from CytomX Therapeutics, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1501989/000161071725000020/0001610717-25-000020-index.htm ↗

Filer's full EDGAR submission history

EDGAR · CytomX Therapeutics, Inc. (0001501989) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.